-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Moderna, Raises Price Target to $95

Benzinga·10/07/2026 14:51:32
Listen to the news
Morgan Stanley analyst Terence Flynn maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and raises the price target from $89 to $95.